mrinalini krishnan, m.d. troy moritz, d.o., facos pinnaclehealth harrisburg hospital harrisburg, pa
TRANSCRIPT
Mrinalini Krishnan, M.D.Troy Moritz, D.O., FACOS
PinnacleHealth Harrisburg HospitalHarrisburg, PA
THE ‘UNTAPPED’ POTENTIALOF TUNNELED
PLEURAL CATHETERS(pun intended)
Purpose: assess the off-label use of Tunneled Pleural Catheters (TPCs) to ‘tap’ recurrent non-malignant pleural effusions secondary to chronic end-stage diseases
Hypothesis: placement of TPCs will decrease in-patientre-admissions for exacerbations of pleural effusions
Retrospective chart review of 98 patients – 37 patients included with recurrent, non-malignant pleural effusions
Patients set up with homecare support, draining 2-3 times per week, and followed out-patient until catheter removal
Background / Methodology
Patient Characteristics Total Number of Patients 37
Age (Mean, SD, Range) 73.95 + 13.43 30 – 92
Gender (Female, n, %) 17 45.95% Co-morbid Conditions (n,%) Hypertension 32 86.49%
Chronic Kidney Disease 22 59.46%
Congestive Heart Failure 25 67.57%
Liver Disease 4 10.81%
Malnutrition 8 21.62%
Multiple Conditions 33 89.19%
Re-admissions Before &After TPC Placed (n=37)
The average re-admission rates for all measures with TPC intervention are significantly reduced, p<0.0001
Readmissions within one year
Readmissions within 3 months
0102030405060
59
42
156
Before TPC placedAfter TPC placed
Re-admissions Before & After TPC Removed (n=31)
Readmissions within one year
Readmissions within 3 months
0102030405060
60
33
9 2
Before TPC removedAfter TPC removed
Re-admissions significantly decreasedin 3 months and 1 year before to after TPC was placed, as well as removed
Both statistically significant, p<0.0001
In conclusion, placement of Tunneled Pleural Catheters decrease in-patientre-admissions in non-malignant pleural effusions, and placing these catheters can ‘tap’ this statistically significant application of TPCs
Results / Conclusion